- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 21, 2026 | 106.98M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 108.39M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 111.03M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $34.99M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $25M |
| Capex | Q1 2026 · Mar 31, 2026 | $14.92M |
| Capex | Q1 2026 · Mar 31, 2025 | $13.47M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.7M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$11.79M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.51B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $1.24B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $283.92M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $466.39M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.65B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.64B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.48B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.53B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.26B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.59B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.68B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.01B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $5.77B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.49 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.60 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.49 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.62 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $267.9M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $244.06M |
| Net Income | Q1 2026 · Mar 31, 2026 | $52.93M |
| Net Income | Q1 2026 · Mar 31, 2025 | $66.2M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $95.67M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $109.23M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.13B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $1.2B |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.49B |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.55B |